Clover Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Clover heeft een totaal eigen vermogen van A$67.1M en een totale schuld van A$8.5M, wat de schuld-eigenvermogensverhouding op 12.6% brengt. De totale activa en totale passiva bedragen respectievelijk A$84.4M en A$17.3M. De EBIT Clover is A$3.1M waardoor de rentedekking 3.5 is. Het heeft contanten en kortetermijnbeleggingen van A$12.3M.

Belangrijke informatie

12.6%

Verhouding schuld/eigen vermogen

AU$8.47m

Schuld

Rente dekkingsratio	3.5x
Contant	AU$12.26m
Aandelen	AU$67.07m
Totaal verplichtingen	AU$17.32m
Totaal activa	AU$84.39m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$56.9M ) CLV } overtreffen de korte termijn passiva ( A$9.8M ).

Langlopende schulden: De kortetermijnactiva CLV ( A$56.9M ) overtreffen de langetermijnschulden ( A$7.5M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: CLV heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van CLV is de afgelopen 5 jaar gedaald van 29.8% naar 12.6%.

Schuldendekking: De schuld van CLV wordt goed gedekt door de operationele kasstroom ( 99.8% ).

Rentedekking: De rentebetalingen op de schuld van CLV worden goed gedekt door EBIT ( 3.5 x dekking).

Clover Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Dividend of AU$0.0075 announced

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

New major risk - Revenue and earnings growth

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Independent Non-Executive Chairman recently bought AU$100k worth of stock

Now 23% undervalued after recent price drop

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023

Insufficient new directors

Clover Corporation Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Market cap size

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022

Clover Informs Study Results by the South Australian Health and Medical Research Institute

Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022

Upcoming dividend of AU$0.01 per share

Clover Corporation Limited, Annual General Meeting, Nov 24, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Now 23% undervalued after recent price drop

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Investor sentiment improved over the past week

CFO & Company Secretary has left the company

Investor sentiment deteriorated over the past week

Clover Corporation Ltd Announces Payment of Interim Dividend for the Half Year Ended January 31, 2021

Investor sentiment improved over the past week

First half 2021 earnings released: EPS AU$0.015 (vs AU$0.028 in 1H 2020)

Clover Corporation Limited Provides Revenue Guidance for the Fiscal Year 2021

Clover Corporation Limited Declares Dividend for the First Half of 2021, Payable on April 29, 2021

New 90-day low: AU$1.45

New 90-day low: AU$1.47

New 90-day low: AU$1.62

CEO, MD & Director recently sold AU$404k worth of stock

Independent Chairman recently bought AU$99k worth of stock

Clover Corporation Limited Announces Board Changes

New 90-day low: AU$2.00

New 90-day low: AU$2.10

Full year earnings released

New 90-day high - AU$2.40

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven